| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |